Ancount 300mcg Injection

About

Ancount 300mcg Injection contains filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). G-CSF is a cytokine that regulates the production and release of neutrophils from the bone marrow. Filgrastim works by stimulating the proliferation, differentiation, and activation of neutrophil precursors, leading to an increase in the number of circulating neutrophils. This makes it crucial for preventing and treating neutropenia, a common side effect of chemotherapy that increases the risk of serious infections. It helps patients maintain their chemotherapy schedules and reduces the incidence of febrile neutropenia.

Uses

• Reduction of incidence of febrile neutropenia in chemotherapy.
• Treatment of severe chronic neutropenia.
• Mobilization of peripheral blood progenitor cells for transplantation.
• Reduction of duration of neutropenia in bone marrow transplant.

Directions For Use

Administered by subcutaneous injection or intravenous infusion.
Follow your healthcare provider's instructions for dosage and administration.

Benefits

• Significantly reduces risk of infection.
• Helps maintain chemotherapy schedules.
• Reduces duration of neutropenia.
• Improves patient safety during cancer treatment.
• Supports bone marrow recovery.
• Enhances neutrophil production.

Side Effects

• Bone pain
• Muscle pain
• Headache
• Fatigue
• Nausea
• Diarrhea
• Injection site reactions
• Splenomegaly (enlarged spleen)
• Thrombocytopenia
• Leukocytosis
• Allergic reactions
• Acute respiratory distress syndrome (rare)

Safety Measures

• Alcohol - No specific interaction with alcohol is known, but general health advice to limit intake applies.
• Pregnancy - Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding - It is unknown if filgrastim is excreted in human milk. Exercise caution when administering to a nursing mother.
• Liver - No specific dose adjustment is typically required for patients with hepatic impairment.
• Kidney - No specific dose adjustment is typically required for patients with renal impairment.
• Lung - Rare cases of acute respiratory distress syndrome (ARDS) have been reported; monitor for pulmonary symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.